News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amstem Corporation (Formerly Known as Stem Cell Therapy International Corp.) Appoints Neuro-Oncology Expert Dr. Michael J. Glantz to Scientific and Medical Board of Advisors


10/5/2010 10:38:13 AM

SAN FRANCISCO & SEOUL, South Korea--(BUSINESS WIRE)--AmStem Corporation (Pink Sheets: AMST), a leading provider of biotherapeutic and cosmetic stem cell products, stem cell collection and storage expertise and access to nanotechnology vital to stem cell research, announced today the appointment of Dr. Michael J. Glantz, M.D. to its Scientific and Medical Board of Advisors (SAMBA).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES